TECENTRIQ CONCENTRATE FOR SOLUTION FOR INFUSION 840MG/14ML
Product details
Registration number: SIN15964P
Classification: Prescription Only
Active ingredients: Atezolizumab
Strength: 840mg/14ml
Dosage form: INFUSION, SOLUTION CONCENTRATE
Route: INTRAVENOUS
Registrant: ROCHE SINGAPORE PTE. LTD.
ATC code: L01FF05
HSA approval date: 25 June 2020
Manufacturer(s): F. Hoffmann-La Roche Ltd
Manufacturing country/countries: SWITZERLAND
What are the HSA registration number and classification for TECENTRIQ CONCENTRATE FOR SOLUTION FOR INFUSION 840MG/14ML?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN15964P
Classification: Prescription Only
What active ingredients and strength are recorded for TECENTRIQ CONCENTRATE FOR SOLUTION FOR INFUSION 840MG/14ML?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Atezolizumab
Strength: 840mg/14ml
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for TECENTRIQ CONCENTRATE FOR SOLUTION FOR INFUSION 840MG/14ML?
According to the HSA dataset updated 7 August 2026:
Dosage form: INFUSION, SOLUTION CONCENTRATE
Route: INTRAVENOUS
Who is the recorded registrant for TECENTRIQ CONCENTRATE FOR SOLUTION FOR INFUSION 840MG/14ML?
According to the HSA dataset updated 7 August 2026:
Registrant: ROCHE SINGAPORE PTE. LTD.
Which manufacturers and countries are listed for TECENTRIQ CONCENTRATE FOR SOLUTION FOR INFUSION 840MG/14ML?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): F. Hoffmann-La Roche Ltd
Manufacturing country/countries: SWITZERLAND
Where can I look up TECENTRIQ CONCENTRATE FOR SOLUTION FOR INFUSION 840MG/14ML in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN15964P or the exact product name TECENTRIQ CONCENTRATE FOR SOLUTION FOR INFUSION 840MG/14ML. The general register link does not preselect this product.
What are the source dates for this TECENTRIQ CONCENTRATE FOR SOLUTION FOR INFUSION 840MG/14ML record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this TECENTRIQ CONCENTRATE FOR SOLUTION FOR INFUSION 840MG/14ML record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN15964P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)